liothyronine sodium
liothyronine sodium is a pharmaceutical drug with 7 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
2
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
85.7%
6 of 7 finished
14.3%
1 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy
Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study
A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
A Study of T3 Therapy in Patients With Hypothyroidism
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
Clinical Trials (7)
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy
Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study
A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin
A Study of T3 Therapy in Patients With Hypothyroidism
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
A Study of Sustained-Release Liothyronine Sodium (T3) in Healthy Subjects
Peri-operative Oral Triiodothyronine Replacement Therapy to Decrease the Risk of Transient Atrial Fibrillation After Off-pump Coronary Artery Bypass Surgery
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7